NASDAQ:BJDX

Bluejay Diagnostics Stock Insider Trading

Healthcare > Medical - Devices

Buy BJDX

*Your capital is at risk

$0.86

-0.0693 (-7.46%)

At Close: Jul 31, 2026

Bluejay Diagnostics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 67.80. In total, the insiders bought 2.02M and sold 224.79K BJDX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	67.80
● Buy	2.02M shares
● Sell	224.79K shares
95% Buy Activity Weak Negative Correlation
Sell Signal Low Confidence Jul 10, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 67.8. Signal is based on a moderate data reliability score of 70.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 01, 2023 Buy	Common Stock A-Award	Dey Indranil President And CEO	CEO / President	159 090 Value: $70.0K
Feb 01, 2023 Sell	Common Stock F-InKind	Dey Indranil President And CEO	CEO / President	55 612 Value: $24.5K
Feb 01, 2023 Buy	Common Stock A-Award	Fisher Kenneth R Chief Financial Officer	C-Suite Officer	112 500 Value: $49.5K
Feb 01, 2023 Sell	Common Stock F-InKind	Fisher Kenneth R Chief Financial Officer	C-Suite Officer	39 316 Value: $17.3K
Feb 01, 2023 Buy	Common Stock A-Award	Zeidman Fred S Director	Director	27 500 Value: $12.1K
Feb 01, 2023 Buy	Common Stock A-Award	Wurth Douglas Clark Director	Director	27 500 Value: $12.1K
Aug 26, 2022 Buy	Common Stock P-Purchase	Fisher Kenneth R Chief Financial Officer	C-Suite Officer	20 000 Value: $20.6K
Aug 26, 2022 Buy	Common Stock P-Purchase	Fisher Kenneth R Chief Financial Officer	C-Suite Officer	20 000 Value: $20.6K
Apr 25, 2022 Buy	Common Stock P-Purchase	Fisher Kenneth R Chief Financial Officer	C-Suite Officer	20 000 Value: $19.8K
Apr 25, 2022 Buy	Common Stock P-Purchase	Fisher Kenneth R Chief Financial Officer	C-Suite Officer	20 000 Value: $19.8K
Mar 23, 2022 Buy	Option (right to buy) A-Award	Fisher Kenneth R Chief Financial Officer	C-Suite Officer	65 000 Value: $0
Mar 23, 2022 Buy	Option (right to buy) A-Award	Fisher Kenneth R Chief Financial Officer	C-Suite Officer	65 000 Value: $85.2K
Mar 23, 2022 Buy	Common Stock J-Other	Fisher Kenneth R Officer	Officer	0 Value: $0
Mar 23, 2022 Buy	Option (right to buy) A-Award	Fisher Kenneth R Chief Financial Officer	C-Suite Officer	65 000 Value: $0
Mar 23, 2022 Buy	Option (right to buy) A-Award	Fisher Kenneth R Chief Financial Officer	C-Suite Officer	65 000 Value: $85.2K
Mar 23, 2022 Buy	Common Stock J-Other	Fisher Kenneth R Officer	Officer	0 Value: $0
Mar 22, 2022 Buy	Option to purchase common stock A-Award	Gemignani Gary G	Director	2 500 Value: $0
Mar 22, 2022 Buy	Option to purchase common stock A-Award	Chase Donald R	Director	2 500 Value: $0
Mar 22, 2022 Buy	Option to purchase common stock A-Award	Zeidman Fred S	Director	2 500 Value: $0
Mar 22, 2022 Buy	Option to purchase common stock A-Award	Zeidman Fred S Director	Director	2 500 Value: $3K
Mar 22, 2022 Buy	Option to purchase common stock A-Award	Wurth Douglas Clark	Director	2 500 Value: $0
Mar 22, 2022 Buy	Option to purchase common stock A-Award	Dey Svetlana	Director	2 500 Value: $0
Mar 22, 2022 Buy	Option to purchase common stock A-Award	Gemignani Gary G	Director	2 500 Value: $0
Mar 22, 2022 Buy	Option to purchase common stock A-Award	Chase Donald R	Director	2 500 Value: $0
Mar 22, 2022 Buy	Option to purchase common stock A-Award	Zeidman Fred S	Director	2 500 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BLUEJAY DIAGNOSTICS, INC.

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reag...

Read Full Profile Here